TrialThe Journal of clinical investigation2021

Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19.

Sixten Körper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.